Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00943254 · ClinicalTrials.gov registry record · NA
Metabolic Syndrome Diagnosis and Education Trial
A NA study of Metabolic Cardiovascular Syndrome, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT00943254: Completed NA study of Metabolic Cardiovascular Syndrome, sponsored by Mayo Clinic.
NCT00943254 is a NA study of Metabolic Cardiovascular Syndrome that has completed, run by Mayo Clinic. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00943254, a NA study of Metabolic Cardiovascular Syndrome, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets on your readiness to increase the subject's level of exercise, lose more weight, eat a healthier diet; and to assess the subject's awareness of their risk of heart disease and their readiness to participate in a comprehensive lifestyle modification program.
Conditions Studied
Interventions
- OTHER High-Tech Education
- OTHER Low-Tech Education
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-08 |
| Phase | NA |
What the finished NCT00943254 record still lists
NCT00943254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Metabolic Cardiovascular Syndrome appearing as the primary indexed condition, and to 2 interventions - of which High-Tech Education is the first listed.
NCT00943254 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00943254 about?
NCT00943254 is a clinical study titled "Metabolic Syndrome Diagnosis and Education Trial". This study is being done to gain knowledge on how effective different approaches of providing a diagnosis and varying educational tools that include DVDs and multimedia or printed instruction sheets on your readiness to increase the subject's level of exercise, lose more weight, eat a healthier diet...
What is the current status of trial NCT00943254?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2007-10. Estimated completion is 2010-08.
What conditions does trial NCT00943254 study?
This clinical trial studies the following conditions: Metabolic Cardiovascular Syndrome.
What interventions are being tested in trial NCT00943254?
The interventions under investigation include: High-Tech Education (OTHER), Low-Tech Education (OTHER).
Who is sponsoring clinical trial NCT00943254?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00943254 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Cardiovascular Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00943254's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia